What have we learnt and translation to the clinic?

被引：0
|
作者：
Acosta, O. [1 ]
机构：
[1] Univ Rennes, CLCC Eugene Marquis, INSERM, LTSI UMR 1099,IMPACT Team,Radiotherapy Dept, Rennes, France
来源：
RADIOTHERAPY AND ONCOLOGY | 2022年 / 170卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
SP-1017
引用
收藏
页码：S862 / S863
页数：2
相关论文
共 50 条
  • [1] HSP90 INHIBITORS IN THE CLINIC: WHAT HAVE WE LEARNT?
    Banerji, U.
    ANNALS OF ONCOLOGY, 2015, 26 : 11 - 11
  • [2] What have we really learnt?
    Tremblay, Michael
    BMJ-BRITISH MEDICAL JOURNAL, 2008, 337
  • [3] Lubrizol: what have we learnt?
    Borraz, Olivier
    ENVIRONNEMENT RISQUES & SANTE, 2021, 20 (02): : 191 - 197
  • [4] Assessment What have we learnt?
    Modelski, George
    Devezas, Tessaleno
    Thompson, William R.
    GLOBALIZATION AS EVOLUTIONARY PROCESS: MODELING GLOBAL CHANGE, 2008, 10 : 417 - 430
  • [5] What Have We Learnt From Chernobyl? What Have We Still To Learn?
    Thomas, G. A.
    Tronko, M. D.
    Tsyb, A. F.
    Tuttle, R. M.
    CLINICAL ONCOLOGY, 2011, 23 (04) : 229 - 233
  • [6] Development effectiveness: What have we learnt?
    Collier, P
    Dollar, D
    ECONOMIC JOURNAL, 2004, 114 (496): : F244 - F271
  • [7] COPD in farmers: what have we learnt?
    Elliott, Leslie
    von Essen, Susanna
    EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (01) : 16 - 18
  • [8] CUP and chemotherapy: what have we learnt?
    Massard, C.
    Fizazi, K.
    ONCOLOGIE, 2008, 10 (12) : 728 - 732
  • [9] The Wrist Series – What Have We Learnt?
    Andrew E. Ajani
    Ron Waksman
    Herz, 2002, 27 : 23 - 29
  • [10] What have we learnt from Vioxx?
    Krumholz, Harlan
    Ross, Joseph S.
    Presler, Amos H.
    Egilman, David S.
    BMJ-BRITISH MEDICAL JOURNAL, 2007, 334 (7585): : 120 - 123
12345